{
"title": "Neurotransmitter receptor density across brain regions from PET atlas studies",
"papers": [
{
"n": 1200,
"doi": "10.1038/s41593-022-01186-3",
"unit": "PET binding potential",
"value": "atlas of 19 receptors across 9 neurotransmitter systems",
"method": "PET",
"region": "whole brain",
"receptor": "Multi-receptor (19 types)",
"value_source_sentence": "Here we collate positron emission tomography data from more than 1,200 healthy individuals to construct a whole-brain three-dimensional normative atlas of 19 receptors and transporters across nine different neurotransmitter systems."
},
{
"n": 210,
"doi": "10.1523/jneurosci.2830-16.2016",
"unit": "PET binding + picomoles/mL",
"value": "high correlation between PET binding and autoradiography protein levels",
"method": "PET + autoradiography",
"region": "whole brain",
"receptor": "5-HT system (5-HT1A, 5-HT1B, 5-HT2A, 5-HT4, 5-HTT)",
"value_source_sentence": "Comparison of the regional PET binding measures with postmortem human brain autoradiography outcomes showed a high correlation for the five 5-HT targets"
},
{
"n": null,
"doi": "10.2967/jnumed.120.246967",
"unit": "PET binding potential",
"value": "high in cortex and hippocampus, moderate in striatum, low in thalamus and cerebellum",
"method": "PET",
"region": "cortex > hippocampus > striatum > thalamus > cerebellum",
"receptor": "M1 muscarinic",
"value_source_sentence": "This was a first-in-human study of the PET radiotracer 11C-LSN3172176 for the muscarinic acetylcholine receptor subtype 1 (M1)"
},
{
"n": null,
"doi": "10.1016/s0028-3908(03)00050-9",
"unit": "PET ligand uptake",
"value": "greatly decreased uptake in M2 KO but not M1/M3/M4 KO",
"method": "PET + knockout validation",
"region": "regional brain",
"receptor": "M2 muscarinic",
"value_source_sentence": "Regional brain uptake of the muscarinic ligand, [18F]FP-TZTP, is greatly decreased in M2 receptor knockout mice but not in M1, M3 and M4 receptor knockout mice."
},
{
"n": null,
"doi": "10.1186/s13550-020-00650-0",
"unit": "SPECT binding potential",
"value": "quantifiable striatal and extrastriatal D2/3",
"method": "SPECT",
"region": "striatal + extrastriatal",
"receptor": "D2/D3 dopamine",
"value_source_sentence": "In vivo absolute quantification of striatal and extrastriatal D2/3 receptors"
}
],
"x_axis": "Brain region",
"y_axis": "Relative receptor density (normalized)",
"n_analyzed": "varies by study: 1200, 210, not reported",
"n_definition": "number of subjects scanned",
"scope_region": "whole brain, multiple regions",
"comparison_id": "fig_sec3_receptor_density_regions",
"comparison_type": "cross-regional receptor density",
"taxonomic_level": "receptor subtype",
"scope_population": "healthy humans and rodent models",
"homogeneity_check": "Studies use different imaging modalities (PET, SPECT, autoradiography) and species (human, mouse). Hansen atlas provides normalized cross-receptor comparison; individual studies provide receptor-specific regional detail. Direct numerical comparison across studies requires normalization to common scale. Caution: PET binding potential is not directly comparable to autoradiographic density measurements."
}